Literature DB >> 7838640

Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome.

J E Gray1, D K Richardson, M C McCormick, D A Goldmann.   

Abstract

OBJECTIVE: To examine the impact of admission-day illness severity on nosocomial bacteremia risk after consideration of traditional risk determinants such as birth weight and length of stay.
METHODS: The hospital courses for 302 consecutive very low birth weight (less than 1500 g) infants admitted to two neonatal intensive care units were examined for the occurrence of nosocomial coagulase-negative staphylococcal bacteremia. Using both cumulative incidence and incidence density as measures of bacteremia risk, we explored the relation between illness severity (as measured by the Score for Neonatal Acute Physiology [SNAP]) and bacteremia both before and after birth weight adjustment. In addition, the effect of bacteremia on hospital resource use was estimated.
RESULTS: Coagulase-negative staphylococcus was the most common pathogen noted in blood cultures drawn at 48 hours after admission or later. It was isolated on at least one occasion in 53 patients (cumulative incidence of 17.5 first episodes per 100 patients). These episodes occurred during 7652 days at risk, giving an incidence density of 6.9 initial bacteremias per 1000 patient-days at risk. As expected, when compared with the nonbacteremic group, bacteremic patients were of lower birth weight (888 +/- 231 vs 1127 +/- 258 g; P < .01) and gestational age (26.4 +/- 2.1 vs 28.9 +/- 2.8 weeks; P < .01). In addition, these patients were more severely ill on admission (SNAP 17.3 +/- 6.5 vs 12.2 +/- 5.8; P < .01). Even after birth weight stratification, the risk of bacteremia by both measures increased with higher SNAP scores. For example, among infants with birth weights greater than 1 kg, 25% of the most severely ill patients (SNAP 20 and higher) experienced at least one bacteremic episode, whereas the rates seen in infants with intermediate (SNAP 10 to 19) and low illness severity (SNAP 0 to 9) were 8.6% and 3.0%, respectively (chi 2 for trend = 7.25; P < .01). Multivariate linear regression showed that bacteremia was associated with a prolongation of neonatal intensive care unit stay of 14.0 +/- 4.0 days (P < .01) and an increase in hospital charges of $25,090 +/- 12,051 (P < .05), even after adjustment for birth weight and admission-day SNAP.
CONCLUSIONS: Nosocomial coagulase-negative bacteremia is an important complication among very low birth weight infants. Assessment of illness severity with SNAP provides information regarding nosocomial infection risk beyond that available from birth weight alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7838640

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  23 in total

Review 1.  Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Curr Opin Infect Dis       Date:  2010-06       Impact factor: 4.915

Review 2.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

3.  CRIB and performance indicators for neonatal intensive care units (NICUs)

Authors:  W Tarnow-Mordi; G Parry; C Gould; P Fowlie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

4.  The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit.

Authors:  G D I de Silva; M Kantzanou; A Justice; R C Massey; A R Wilkinson; N P J Day; S J Peacock
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  The efficacy of clinical strategies to reduce nosocomial sepsis in extremely low birth weight infants.

Authors:  Jong Hee Hwang; Chang Won Choi; Yun Sil Chang; Yon Ho Choe; Won Soon Park; Son Moon Shin; Munhyang Lee; Sang Il Lee
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

6.  Changing patterns of blood borne sepsis in special care baby unit, khoula hospital.

Authors:  Bhaskar Gupta; Eisa El Amin
Journal:  Oman Med J       Date:  2010-04

Review 7.  Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review.

Authors:  Sundar Sathiyamurthy; Jayanta Banerjee; Sunit V Godambe
Journal:  World J Clin Pediatr       Date:  2016-05-08

Review 8.  Vancomycin: pharmacokinetics and administration regimens in neonates.

Authors:  Matthijs de Hoog; Johan W Mouton; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates.

Authors:  Leonard E Weisman; Helen M Thackray; Joseph A Garcia-Prats; Mirjana Nesin; Joseph H Schneider; Jennifer Fretz; John F Kokai-Kun; James J Mond; William G Kramer; Gerald W Fischer
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

Review 10.  The developing human preterm neonatal immune system: a case for more research in this area.

Authors:  Ashish Arunkumar Sharma; Roger Jen; Alison Butler; Pascal M Lavoie
Journal:  Clin Immunol       Date:  2012-08-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.